The global biochip market size is expected to reach USD 34.35 Billion in 2030 and register a revenue CAGR of 11.5% over the forecast period, according to the latest report by Reports and Data. Increasing application of biochips in proteomics, genomics, and drug discovery coupled with high investment in Research & Development (R&D) is driving market revenue growth.
Biochip technologies have a significant impact on genomic research because high-density microarray chips with relatively large detection systems are useful in research laboratories for monitoring the expression of large numbers of genes in parallel. However, small and inexpensive integrated biochips that combine probe arrays with sensor microchips are most suitable for medical diagnosis at the site of care. Various fields such as drug discovery, gene discovery, medical diagnostics, and toxicological research are benefitting from the use of biochip technologies.
Biochips are increasingly being utilized within the field of biomedical and biotechnological research. With headway in innovation, there has been a rise in adoption of biochips in proteomics, such as in microarrays. The benefits of protein biochips include low test consumption and its inclination toward miniaturization. These characteristics of microarrays are imperative for proteome-wide analysis.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Key Players covered in this report are
bioMerieux SA, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Fluidigm, Illumina, Inc., HORIBA, Ltd., PerkinElmer, Inc., QIAGEN, Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.
Product Outlook (Revenue, USD Billion; 2019-2030)
- DNA Chip
- Lab - on - Chip
- Protein Chip
- Others
Application Type Outlook (Revenue, USD Billion; 2019-2030)
- Genomics
- Proteomics
- In-Vitro Diagnostics
- Disease Diagnostics
- Agriculture
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Request a sample Report of Biochips Market @ https://www.reportsanddata.com/sample-enquiry-form/1375
Major Points covered in this report are as below:
• The Biochips industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
• The Biochips Market report provides key statistics on the market status of the Biochips manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Get More Reports:
Solvent Evaporation Market @ https://www.biospace.com/article/solvent-evaporation-market-to-reach-usd-926-8-million-by-2028-with-cagr-of-7-5-percent-says-reports-and-data/
Dual Chamber Prefilled Syringes Market @ https://www.biospace.com/article/dual-chamber-prefilled-syringes-market-to-reach-usd-223-3-million-by-2028-says-reports-and-data/
Protein Crystallization & Crystallography Market @ https://www.biospace.com/article/protein-crystallization-and-crystallography-market-size-to-reach-usd-2-23-billion-in-2028-says-reports-and-data/
Slide Stainers Market @ https://www.biospace.com/article/slide-stainers-market-size-to-reach-usd-8-02-billion-by-2028-says-reports-and-data/
Mice Model Market @ https://www.biospace.com/article/mice-model-market-size-to-reach-usd-2-49-billion-by-2028-says-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.